Yahoo
Irish EUR

Glanbia plc (GL9.IR)

20.86 +0.58 (+2.86%)
At close: October 30 at 4:33:07 PM GMT
GL9.IR Q3 2026 earnings call
November 4, 2026 at 8:30 AM GMT
Chart Range Bar
Loading chart for GL9.IR
  • Previous Close 20.28
  • Open 20.42
  • Bid 20.64 x 2908600
  • Ask 21.40 x 6209100
  • Day's Range 20.42 - 20.86
  • 52 Week Range 14.09 - 25.10
  • Volume 411,889
  • Avg. Volume 483,713
  • Market Cap (intraday) 5.042B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 25.13
  • EPS (TTM) 0.83
  • Earnings Date Aug 6, 2026
  • Forward Dividend & Yield 0.45 (2.14%)
  • Ex-Dividend Date Aug 20, 2026
  • 1y Target Est 24.06

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

www.glanbia.com

4,963

Full Time Employees

January 03

Fiscal Year Ends

Packaged Foods

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is ISEQ All Share (^ISEQ) .

YTD Return

GL9.IR
46.68%
ISEQ All Share (^ISEQ)
8.23%

1-Year Return

GL9.IR
45.08%
ISEQ All Share (^ISEQ)
20.02%

3-Year Return

GL9.IR
55.72%
ISEQ All Share (^ISEQ)
81.91%

5-Year Return

GL9.IR
68.09%
ISEQ All Share (^ISEQ)
66.14%

Analyst Insights

View More

Analyst Price Targets

20.14
24.06 Average
20.86 Current
27.71 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.80%

  • Return on Assets (ttm)

    6.22%

  • Return on Equity (ttm)

    12.05%

  • Revenue (ttm)

    4.1B

  • Net Income Avi to Common (ttm)

    237.7M

  • Diluted EPS (ttm)

    0.83

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    375.7M

  • Total Debt/Equity (mrq)

    63.69%

  • Levered Free Cash Flow (ttm)

    335.58M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: